IGEA Pharma N.V. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported net loss was EUR 11.69 million compared to EUR 1.23 million a year ago. Basic loss per share from continuing operations was EUR 0.0347 compared to EUR 0.0039 a year ago.
IGEA Pharma N.V.
Equities
IGPH
NL0012768675
Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | |
---|---|---|
+0.89% | 12.8B | |
-10.29% | 7.61B | |
+1.78% | 5.41B | |
-1.16% | 4.51B | |
+5.74% | 4.49B | |
-50.70% | 3.29B | |
+12.21% | 2.73B | |
-16.13% | 2.02B | |
-11.50% | 1.73B |